jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Jan. 06, 2025

Jan. 06, 2025

jRCT1051240235

Research on chronic pain treatment with human-derived mesenchymal stem cell conditioned medium

Research on chronic pain ttreatment with MSC-CM

Takigawa Shingo

Kawagoe Chuou Cinic

Saitamaken kawagoeshi Wakitahoncho 1-5

+81-49-220-5500

kawagoe-ccl@kowakai-medical.or.jp

Yoshikazu Ishiwata

Kawagoe Chuou Cinic

Saitamaken kawagoeshi Wakitahoncho 1-5

+81-49-220-5500

y-ishiwata@kowakai-medical.or.jp

Recruiting

Sept. 01, 2023

Observational

1. Patients who did not have a satisfactory therapeutic effect with standard treatment
2. Patients who do not wish to be treated with the drugs used in standard treatment due to concerns about side effects, etc., and those who have been judged by the doctor that chronic pain treatment with conditioned medium is optimal.

<Inclusion criteria>
Target patients who meet the following criteria.
1. 18 years old and over
2. Have normal consent ability
3. Patients who can obtain their free will consent in writing
4. Patients whose doctor have recognized the need for treatment

Patient who meet any of the following conditions are excluded
1. Users of narcotics or stimulants
2. Judged unsuitable by the doctor

18age old over
No limit

Chronic Pain

D059350

Improvement of subjective symptoms

Kawagoe Chuo Clinic
Safety Assessment Committee for Clinical Research Japan (SACRJ)
13-16 Sanjo Minamicho, Ashiya City, Hyogo, Hyogo
jpgh@ace.odn.ne.jp
Approval

Aug. 23, 2023

No

none